Posts

Transformative Advances in Prostate Cancer Care

Image
Transformative Advances in Prostate Cancer Care: 2025 Achievements Reshape the Treatment Paradigm TL;DR - Key Achievements of 2025 FDA Approvals: Five major approvals expanded treatment options including Akeega for BRCA2-mutated early metastatic disease (54% progression reduction), rucaparib full approval for BRCA-mutated mCRPC, darolutamide for hormone-sensitive disease, Pluvicto earlier in treatment sequence (59% progression reduction), and new PSMA PET imaging agent. Clinical Trial Breakthroughs: CAN-2409 gene therapy became first new localized prostate cancer treatment in 20+ years (30% recurrence reduction). TALAPRO-2 showed 8.8-month survival improvement with PARP inhibitor combinations. Terbium-161 radioligand achieved 70% response rate with minimal toxicity. Diagnostic Revolution: AI systems reached clinical maturity for MRI and pathology interpretation, matching expert performance. PSMA PET solidified as standard of care with updated national guidelines and predictive v...
Post a Comment
Read more

Kidney Complications with Pluvicto

Image
What Prostate Cancer Patients Need to Know BLUF (Bottom Line Up Front) Acute kidney injury is a recognized but uncommon serious side effect of Pluvicto (lutetium-177-PSMA-617), occurring in approximately 1-12% of patients depending on severity criteria. While most patients tolerate the treatment well, kidney function monitoring is essential throughout therapy. Patients experiencing progressive side effects, particularly nausea, vomiting, or reduced urination, should seek immediate medical evaluation. Several risk factors increase vulnerability to kidney complications, and alternative treatment sequencing may be considered for high-risk patients. Understanding the Case You've Described The case presented—no PSA response, worsening side effects, and acute renal failure after four Pluvicto cycles—reflects a known but serious complication pattern that clinical teams actively monitor. You're not alone in asking these questions, and understanding what research shows can help pat...
Post a Comment
Read more

Mathematical Modeling Shows Promise for Personalizing Lutetium-177 PSMA Therapy in Advanced Prostate Cancer

Image
Understanding the Mathematical Model: A Visual Guide This diagram shows how researchers created a computer model to simulate what happens in your body during Lutetium-177 PSMA therapy. Let me break it down into understandable parts: The Left Side: What Happens to Cancer Cells The green, orange, and red cells represent different states of prostate cancer cells in your body: Green cells (MTP) - These are actively growing cancer cells They multiply at a rate called "kg" (growth rate) Some can repair themselves (shown by the curved arrow with "μT") Orange cells (MTSD) - These are damaged but not yet dead Cancer cells hit by radiation but not killed immediately They might repair and turn back into green cells, OR They might get hit again and die Red cells (MTD) - These are lethally damaged, dying cells Cancer cells that have been fatally damaged by radiation They get cleared away from your body at rate "kc" The yellow lightning bolt (AT) represent...
Post a Comment
Read more